- Home
- BKSY vs ESPR Comparison
BKSY vs ESPR Comparison
Compare BKSY & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- ESPR
- Stock Information
- Founded
- BKSY 2013
- ESPR 2008
- Country
- BKSY United States
- ESPR United States
- Employees
- BKSY N/A
- ESPR N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- ESPR Health Care
- Exchange
- BKSY Nasdaq
- ESPR Nasdaq
- Market Cap
- BKSY 303.5M
- ESPR 305.0M
- IPO Year
- BKSY N/A
- ESPR 2013
- Fundamental
- Price
- BKSY $6.93
- ESPR $1.06
- Analyst Decision
- BKSY Strong Buy
- ESPR Buy
- Analyst Count
- BKSY 5
- ESPR 7
- Target Price
- BKSY $21.80
- ESPR $6.21
- AVG Volume (30 Days)
- BKSY 971.0K
- ESPR 4.4M
- Earning Date
- BKSY 05-07-2025
- ESPR 05-06-2025
- Dividend Yield
- BKSY N/A
- ESPR N/A
- EPS Growth
- BKSY N/A
- ESPR N/A
- EPS
- BKSY N/A
- ESPR N/A
- Revenue
- BKSY $102,093,000.00
- ESPR $332,314,000.00
- Revenue This Year
- BKSY $31.99
- ESPR $5.17
- Revenue Next Year
- BKSY $27.21
- ESPR N/A
- P/E Ratio
- BKSY N/A
- ESPR N/A
- Revenue Growth
- BKSY 8.04
- ESPR 185.66
- 52 Week Low
- BKSY $3.86
- ESPR $1.04
- 52 Week High
- BKSY $21.92
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- BKSY 30.78
- ESPR 21.84
- Support Level
- BKSY $7.29
- ESPR $1.35
- Resistance Level
- BKSY $8.27
- ESPR $1.75
- Average True Range (ATR)
- BKSY 0.68
- ESPR 0.10
- MACD
- BKSY 0.02
- ESPR -0.04
- Stochastic Oscillator
- BKSY 21.43
- ESPR 2.80
Stock Price Comparison Chart: BKSY vs ESPR
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.